Dr Susan Cox (Senior Vice President Drug Development)

Dr Cox graduated with a PhD in Virology from the Karolinska Institute in 1991, and became an associate professor in 1994. She has 15 years experience in antiviral drug discovery. Dr Cox worked on the anti-CMV drug Foscavir ® at Astra, and was previously Program Director at Medivir, where she led antiviral research programs from discovery up to and including Phase II studies. Dr Cox joined Amrad Corporation Limited in 1998 and helped establish Avexa, where she currently holds the position of Senior Vice President Drug Development and is responsible for later stage projects.  She has recently been appointed to the Board of the International Society for Antiviral Research (ISAR) and is a graduate of the Australian Institute of Company Directors.